Our president has spouted lots of manure and spread the the good things the drug can do……but read it for yourself…..https://lobotero.com/2020/04/23/hydroxychloroquine-part-2/
The drug that Donald the Orange thinks is the bee’s knees is hydroxychloroquine….but he may be the only person that thinks it is adequate for the treatment of Covid-19….but the FDA does not really agree with the president…..
Hydroxychloroquine and chloroquine no longer have the U.S. Food and Drug Administration’s blessing for use against coronavirus infections when given outside of a clinical trial.
In March, the agency authorized using the malaria drugs for hospitalized patients with COVID-19 who couldn’t participate in clinical trials. But the legal criteria for issuing an emergency use authorization are no longer met, the agency said in a statement June 15.
There is a drug that shows promise but only on patients that are already on a ventilator…..
Researchers running the largest randomized, controlled trial of coronavirus treatments are heralding a “major breakthrough”: the first drug shown to reduce deaths from COVID-19. Dexamethasone isn’t new. Rather, it’s a generic steroid widely used to reduce inflammation. But it’s “the only drug that’s so far shown to reduce mortality [for COVID-19]—and it reduces it significantly,” says Oxford University’s Peter Horby, co-leader of the “Recovery” trial, per the Guardian. Around 2,100 hospitalized patients received 6mg of dexamethasone once a day for 10 days, while about 4,300 patients receive the usual care. Dexamethasone didn’t appear to benefit patients whose treatment excluded respiratory intervention. But it was found to reduce deaths by one-third in ventilated patients (saving one person in eight) and by one-fifth in patients receiving oxygen only (saving one in 25).
This could have a huge impact on death rates, as half of all COVID-19 patients who require ventilators later die, per the BBC. “This is a result that shows that if patients who have COVID-19 and are on ventilators or are on oxygen are given dexamethasone, it will save lives, and it will do so at a remarkably low cost,” says trial co-leader Martin Landray, also of Oxford, per Reuters. The cost of the drugs used in the trial was a little over $6 per patient, per the BBC. And dexamethasone is “easily obtainable anywhere in the world,” reports the Guardian. Landray says hospitalized patients at the greatest risk from the disease should be treated with dexamethasone immediately. In a separate study, the Recovery team found hydroxychloroquine, the drug touted and allegedly taken by President Trump, didn’t benefit patients hospitalized with COVID-19.
There is a drug that can help with symptoms once the infection is detected…..
US regulators on Friday allowed emergency use of an experimental drug that appears to help some coronavirus patients recover faster. It is the first drug shown to help fight COVID-19, which has killed more than 230,000 people worldwide. President Trump announced the news at the White House alongside Food and Drug Administration Commissioner Stephen Hahn, who said the drug would be available for patients hospitalized with COVID-19, the AP reports. The FDA acted after preliminary results from a government-sponsored study showed that Gilead Sciences’s remdesivir shortened the time to recovery by 31%, or about four days on average, for hospitalized COVID-19 patients. The study of 1,063 patients is the largest and most strict test of the drug and included a comparison group that received just usual care so remdesivir’s effects could be rigorously evaluated.
Those given the drug left the hospital in 11 days on average, versus 15 days for the comparison group. The drug also might be reducing deaths, though that’s not certain so far. Dr. Anthony Fauci said the drug would become a new standard of care for severely ill COVID-19 patients. The drug has not been tested on people with a milder illness, and it’s currently given through an IV in a hospital. The FDA invoked its emergency powers to speed experimental drugs to patients. In normal times, the FDA requires “substantial evidence” of a drug’s safety and effectiveness, usually through one or more large patient studies. But during public health emergencies the agency can waive those standards, simply requiring that a drug’s potential benefits outweigh its risks. Gilead has said it would donate its current stock of the drug and is ramping up production. No drugs are approved now for treating the coronavirus, and remdesivir will still need formal approval.
There is the drug news during the time of a pandemic…..
I Read, I Write, You Know
“lego ergo scribo”